| P50 | author | Olaf Rötzschke | Q102526521 |
| | Paul Kwong Hang Tam | Q67251370 |
| | Francisco Salcido-Ochoa | Q78514348 |
| P2093 | author name string | Kirsten Falk | |
| | Julia Tsang | |
| P2860 | cites work | Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation | Q80512153 |
| | Murine CD4+CD25+ regulatory T cells fail to undergo chromatin remodeling across the proximal promoter region of the IL-2 gene | Q80833054 |
| | A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells | Q81157115 |
| | Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells | Q81245689 |
| | Protection against autoimmunity in nonlymphopenic hosts by CD4+ CD25+ regulatory T cells is antigen-specific and requires IL-10 and TGF-beta | Q81245713 |
| | Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells | Q81357564 |
| | Inducing and expanding regulatory T cell populations by foreign antigen | Q81392563 |
| | Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation | Q24291515 |
| | FOXP3 controls regulatory T cell function through cooperation with NFAT | Q24298179 |
| | Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells | Q24298812 |
| | Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1 | Q24300625 |
| | Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function | Q24305624 |
| | Identification and characterization of CD39/vascular ATP diphosphohydrolase | Q24336540 |
| | Foxp3 occupancy and regulation of key target genes during T-cell stimulation | Q24623384 |
| | Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells | Q24653129 |
| | Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 |
| | Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 |
| | Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 |
| | Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4 | Q28204758 |
| | Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors | Q28268052 |
| | Ecto-enzyme and signaling functions of lymphocyte CD73 | Q28268472 |
| | Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 |
| | A function for interleukin 2 in Foxp3-expressing regulatory T cells | Q28590646 |
| | High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors | Q28592075 |
| | Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression | Q29615344 |
| | CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells | Q29618394 |
| | An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 |
| | The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 | Q29619324 |
| | CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 |
| | Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 |
| | Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice | Q29622850 |
| | Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection | Q30307082 |
| | Identification of the Immunophilins Capable of Mediating Inhibition of Signal Transduction by Cyclosporin A and FK506: Roles of Calcineurin Binding and Cellular Location | Q36694583 |
| | CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects | Q36826059 |
| | Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells | Q36842568 |
| | From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases | Q36932946 |
| | The Foxp3+ regulatory T cell: a jack of all trades, master of regulation | Q37088900 |
| | Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2A agonists | Q30441415 |
| | Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice | Q30498716 |
| | Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses | Q31838449 |
| | Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo | Q33236315 |
| | Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia | Q33629928 |
| | Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells | Q33742099 |
| | In vitro and in vivo analysis of bone marrow-derived CD3+, CD4-, CD8-, NK1.1+ cell lines | Q33854587 |
| | Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae. | Q33886662 |
| | The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. | Q33932690 |
| | Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells | Q33992696 |
| | Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation | Q33993967 |
| | Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 |
| | CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 |
| | Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells | Q34189120 |
| | The role of peripheral T-cell deletion in transplantation tolerance | Q34262660 |
| | Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis | Q34311395 |
| | Role of LAG-3 in regulatory T cells. | Q34358935 |
| | Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism | Q34392100 |
| | Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. | Q34516841 |
| | Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta | Q34517421 |
| | Identification of regulatory T cells in tolerated allografts | Q34524237 |
| | Interleukin 2 signaling is required for CD4(+) regulatory T cell function | Q34527240 |
| | Human T regulatory cells can use the perforin pathway to cause autologous target cell death | Q34551876 |
| | Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells | Q34552979 |
| | Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. | Q34553677 |
| | Altered proximal T cell receptor (TCR) signaling in human CD4+CD25+ regulatory T cells | Q34567368 |
| | Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells | Q34577919 |
| | T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine | Q34578972 |
| | Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression | Q34579516 |
| | Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes | Q34585878 |
| | Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. | Q34621389 |
| | The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation | Q34657284 |
| | CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells | Q34709777 |
| | Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity | Q37100901 |
| | CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance | Q37106789 |
| | Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression | Q37245083 |
| | Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo | Q37312884 |
| | Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells | Q37317866 |
| | TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes | Q37358159 |
| | Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. | Q38305613 |
| | Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease | Q38306073 |
| | Do suppressor T cells exist? | Q39485474 |
| | CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells. | Q40034589 |
| | Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. | Q40110921 |
| | In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity. | Q40197970 |
| | CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer | Q40327394 |
| | Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. | Q40565739 |
| | In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures | Q40576782 |
| | Neuropilin-1: a surface marker of regulatory T cells | Q40584286 |
| | Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. | Q40643930 |
| | CD39 and control of cellular immune responses | Q40730152 |
| | Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E. | Q40779421 |
| | Saying the 'S' word in public. | Q40797288 |
| | Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. | Q40801370 |
| | P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide | Q40806805 |
| | Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific | Q40910998 |
| | Immunology taught by viruses | Q40933905 |
| | Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis | Q41873492 |
| | Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production | Q41908710 |
| | Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells | Q41908906 |
| | Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood | Q41988688 |
| | Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta | Q42096868 |
| | Cutting edge: TGF-beta-induced expression of Foxp3 in T cells is mediated through inactivation of ERK. | Q42159544 |
| | Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state | Q42466421 |
| | Molecular mechanisms underlying FOXP3 induction in human T cells | Q42491664 |
| | Modulation of dendritic cell function by naive and regulatory CD4+ T cells | Q42494637 |
| | Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. | Q42915120 |
| | Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy | Q42971266 |
| | Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery | Q43095588 |
| | The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade | Q44217780 |
| | CD39 modulates IL-1 release from activated endothelial cells | Q44326497 |
| | CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation | Q44408941 |
| | Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. | Q44591644 |
| | Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance | Q44620458 |
| | Impaired T cell receptor signaling in Foxp3+ CD4 T cells | Q44927981 |
| | T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response | Q45292627 |
| | Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. | Q45299244 |
| | Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice | Q46081630 |
| | What does the future hold for cell-based tolerogenic therapy? | Q46228704 |
| | Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells | Q46245992 |
| | Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen | Q46453779 |
| | Clinical-grade preparation of human natural regulatory T-cells encoding the thymidine kinase suicide gene as a safety gene | Q46491860 |
| | CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H. | Q46763767 |
| | Low circulating regulatory T-cell levels after acute rejection in liver transplantation. | Q46919793 |
| | Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells | Q46943431 |
| | Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. | Q47206753 |
| | Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation | Q47367538 |
| | "Infectious" transplantation tolerance. | Q34726892 |
| | Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells | Q34749747 |
| | The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance | Q34769236 |
| | The complementary roles of deletion and regulation in transplantation tolerance | Q35058547 |
| | Alerting and tuning the immune response by extracellular nucleotides | Q35082626 |
| | Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T-cell function in transplantation | Q35087194 |
| | Regulatory T cells in transplantation tolerance | Q35092535 |
| | The balance of deletion and regulation in allograft tolerance. | Q35583506 |
| | Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. | Q35698535 |
| | Regulatory T cells and organ transplantation | Q35703532 |
| | Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis | Q35740840 |
| | Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo | Q35847438 |
| | Adenosine A2a receptors induce heterologous desensitization of chemokine receptors | Q35849780 |
| | Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells | Q35867877 |
| | Cellular distribution and functions of P2 receptor subtypes in different systems | Q35952737 |
| | Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance | Q36024233 |
| | Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells | Q36228688 |
| | Chronic renal allograft dysfunction | Q36240051 |
| | Role of regulatory T cells in human diseases. | Q36308397 |
| | Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation | Q36367099 |
| | Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells | Q36369536 |
| | Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells | Q36371345 |
| | In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes | Q36399048 |
| | CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. | Q36399104 |
| | Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells | Q36399149 |
| | Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction | Q36401408 |
| | Developmental regulation of Foxp3 expression during ontogeny. | Q36403564 |
| | Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro | Q36508920 |
| | Th17: the third member of the effector T cell trilogy | Q36528977 |
| | Why hasn't eliminating acute rejection improved graft survival? | Q36604328 |
| | Regulatory T cell-mediated suppression: potential role of ICER. | Q36617641 |
| | Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation | Q36691082 |
| | T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. | Q36693820 |
| | Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function | Q47579310 |
| | Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells | Q47810559 |
| | Regulatory CD25+ T cells in human kidney transplant recipients | Q47895876 |
| | Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency | Q47992795 |
| | Kidney and pancreas transplantation in the United States, 1995-2004. | Q50112848 |
| | Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. | Q51103369 |
| | Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. | Q51541351 |
| | CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. | Q51995543 |
| | Immobilized anti-CD3 mAb induces anergy in murine naive and memory CD4+ T cells in vitro. | Q52042348 |
| | Regulatory T cells, derived from naïve CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. | Q53674506 |
| | Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. | Q53775010 |
| | Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. | Q53883439 |
| | Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade | Q56901372 |
| | ICER/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells | Q56901469 |
| | Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin | Q56901703 |
| | The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen | Q56902957 |
| | CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses | Q56904642 |
| | CD4(+)CD25(+) T cells facilitate the induction of T cell anergy | Q56904876 |
| | CD4+CD25high regulatory cells in human peripheral blood | Q56905059 |
| | Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment | Q56907406 |
| | Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression | Q57362835 |
| | Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells | Q57920567 |
| | Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium | Q59652622 |
| | IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo | Q60700622 |
| | Critical Influence of Natural Regulatory CD25+ T Cells on the Fate of Allografts in the Absence of Immunosuppression | Q61651649 |
| | Levels of peripheral T cell tolerance induced by different doses of tolerogen | Q72761691 |
| | Rapamycin induces transforming growth factor-beta production by lymphocytes | Q73111942 |
| | Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression | Q73977252 |
| | CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells | Q74012969 |
| | Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction | Q74191513 |
| | The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells | Q74286639 |
| | Anergic T cells act as suppressor cells in vitro and in vivo | Q74578866 |
| | CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2 | Q74660381 |
| | Control of neonatal tolerance to tissue antigens by peripheral T cell trafficking | Q77544864 |
| | Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 |
| | The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality | Q78033315 |
| | Dendritic cells prohibited by anergic T cells acquire tolerogenic properties | Q78514350 |
| | In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance | Q79143624 |
| | Following anti-CD25 treatment, a functional CD4+CD25+ regulatory T-cell pool is present in renal transplant recipients | Q79364663 |
| | Generation and expansion of human CD4+ CD25+ regulatory T cells with indirect allospecificity: Potential reagents to promote donor-specific transplantation tolerance | Q79468642 |
| | CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive | Q79629254 |
| | Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T | Q79834605 |
| | Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells | Q80057973 |
| | Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients | Q80154346 |
| P433 | issue | 2 | |
| P921 | main subject | adenosine triphosphate | Q80863 |
| P304 | page(s) | 52-66 | |
| P577 | publication date | 2010-02-11 | |
| P1433 | published in | Transplantation Reviews | Q15749559 |
| P1476 | title | Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role? | |
| P478 | volume | 24 | |